|
tbar.gif
Click
here to
submit entries
|
|
|
BG
Medicine Enters Biomarker Collaboration with Copenhagen General
Population Study
|
February
12, 2008--
BG Medicine and the Copenhagen General Population Study will collaborate
toward the discovery and validation of novel cardiovascular biomarkers.
The planned research will be conducted as part of BG Medicine’s High
Risk Plaque Initiative, which was started by BG Medicine, Merck,
AstraZeneca, and Philips. BG
Medicine
|
|
|
Genstruct: Patience, Persistence, and Payoff
By John Russell |
|
Finding the right business model for systems biology (SB) technology providers has been challenging — that’s hardly a new theme in biotech.
Click
here
|
|
|
